nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—CYP1A2—Pentoxifylline—systemic scleroderma	0.188	0.512	CbGbCtD
Phenylephrine—CYP1A2—Leflunomide—systemic scleroderma	0.179	0.488	CbGbCtD
Phenylephrine—Hyperhidrosis—Pentoxifylline—systemic scleroderma	0.00258	0.00408	CcSEcCtD
Phenylephrine—Sweating increased—Lisinopril—systemic scleroderma	0.00245	0.00388	CcSEcCtD
Phenylephrine—Tension—Captopril—systemic scleroderma	0.00243	0.00384	CcSEcCtD
Phenylephrine—Dysgeusia—Captopril—systemic scleroderma	0.00243	0.00383	CcSEcCtD
Phenylephrine—Nervousness—Captopril—systemic scleroderma	0.00241	0.0038	CcSEcCtD
Phenylephrine—Chest pain—Mometasone—systemic scleroderma	0.0024	0.0038	CcSEcCtD
Phenylephrine—Dyspnoea—Pentoxifylline—systemic scleroderma	0.00238	0.00376	CcSEcCtD
Phenylephrine—Vision blurred—Captopril—systemic scleroderma	0.00233	0.00369	CcSEcCtD
Phenylephrine—Orthostatic hypotension—Mycophenolate mofetil—systemic scleroderma	0.00233	0.00368	CcSEcCtD
Phenylephrine—Extravasation—Methotrexate—systemic scleroderma	0.00228	0.00361	CcSEcCtD
Phenylephrine—Bradycardia—Mycophenolic acid—systemic scleroderma	0.00228	0.0036	CcSEcCtD
Phenylephrine—Skin exfoliation—Prednisone—systemic scleroderma	0.00228	0.0036	CcSEcCtD
Phenylephrine—Immune system disorder—Azathioprine—systemic scleroderma	0.00224	0.00355	CcSEcCtD
Phenylephrine—Mediastinal disorder—Azathioprine—systemic scleroderma	0.00224	0.00354	CcSEcCtD
Phenylephrine—Syncope—Captopril—systemic scleroderma	0.00222	0.00351	CcSEcCtD
Phenylephrine—Arrhythmia—Azathioprine—systemic scleroderma	0.00222	0.00351	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Lisinopril—systemic scleroderma	0.00221	0.0035	CcSEcCtD
Phenylephrine—Myocardial infarction—Lisinopril—systemic scleroderma	0.0022	0.00348	CcSEcCtD
Phenylephrine—Palpitations—Captopril—systemic scleroderma	0.00219	0.00346	CcSEcCtD
Phenylephrine—Loss of consciousness—Captopril—systemic scleroderma	0.00218	0.00344	CcSEcCtD
Phenylephrine—Cardiac disorder—Leflunomide—systemic scleroderma	0.00218	0.00344	CcSEcCtD
Phenylephrine—Visual impairment—Mycophenolic acid—systemic scleroderma	0.00216	0.00341	CcSEcCtD
Phenylephrine—Pulmonary oedema—Prednisone—systemic scleroderma	0.00212	0.00335	CcSEcCtD
Phenylephrine—Urticaria—Pentoxifylline—systemic scleroderma	0.00212	0.00335	CcSEcCtD
Phenylephrine—Immune system disorder—Leflunomide—systemic scleroderma	0.00212	0.00335	CcSEcCtD
Phenylephrine—Mediastinal disorder—Leflunomide—systemic scleroderma	0.00211	0.00334	CcSEcCtD
Phenylephrine—Chest pain—Captopril—systemic scleroderma	0.00211	0.00333	CcSEcCtD
Phenylephrine—Arrhythmia—Leflunomide—systemic scleroderma	0.0021	0.00331	CcSEcCtD
Phenylephrine—Cardiac disorder—Mycophenolic acid—systemic scleroderma	0.00208	0.00328	CcSEcCtD
Phenylephrine—Paraesthesia—Mometasone—systemic scleroderma	0.00207	0.00327	CcSEcCtD
Phenylephrine—Mental disorder—Leflunomide—systemic scleroderma	0.00205	0.00325	CcSEcCtD
Phenylephrine—Dyspnoea—Mometasone—systemic scleroderma	0.00205	0.00324	CcSEcCtD
Phenylephrine—Bradycardia—Lisinopril—systemic scleroderma	0.00205	0.00324	CcSEcCtD
Phenylephrine—Angiopathy—Mycophenolic acid—systemic scleroderma	0.00203	0.00321	CcSEcCtD
Phenylephrine—Mediastinal disorder—Mycophenolic acid—systemic scleroderma	0.00202	0.00319	CcSEcCtD
Phenylephrine—Dysgeusia—Leflunomide—systemic scleroderma	0.002	0.00316	CcSEcCtD
Phenylephrine—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.002	0.00316	CcSEcCtD
Phenylephrine—Shock—Captopril—systemic scleroderma	0.00199	0.00314	CcSEcCtD
Phenylephrine—Tachycardia—Captopril—systemic scleroderma	0.00197	0.00312	CcSEcCtD
Phenylephrine—Pain—Mometasone—systemic scleroderma	0.00197	0.00311	CcSEcCtD
Phenylephrine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00197	0.00311	CcSEcCtD
Phenylephrine—Mental disorder—Mycophenolic acid—systemic scleroderma	0.00196	0.0031	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Mycophenolate mofetil—systemic scleroderma	0.00194	0.00306	CcSEcCtD
Phenylephrine—Myocardial infarction—Mycophenolate mofetil—systemic scleroderma	0.00193	0.00305	CcSEcCtD
Phenylephrine—Vision blurred—Leflunomide—systemic scleroderma	0.00192	0.00304	CcSEcCtD
Phenylephrine—Tension—Mycophenolic acid—systemic scleroderma	0.00191	0.00302	CcSEcCtD
Phenylephrine—Skin exfoliation—Methotrexate—systemic scleroderma	0.0019	0.00301	CcSEcCtD
Phenylephrine—Nervousness—Mycophenolic acid—systemic scleroderma	0.00189	0.00299	CcSEcCtD
Phenylephrine—Pruritus—Pentoxifylline—systemic scleroderma	0.00189	0.00298	CcSEcCtD
Phenylephrine—Vision blurred—Mycophenolic acid—systemic scleroderma	0.00184	0.0029	CcSEcCtD
Phenylephrine—Angiopathy—Lisinopril—systemic scleroderma	0.00183	0.00289	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.00183	0.00289	CcSEcCtD
Phenylephrine—Tremor—Mycophenolic acid—systemic scleroderma	0.00183	0.00288	CcSEcCtD
Phenylephrine—Mediastinal disorder—Lisinopril—systemic scleroderma	0.00182	0.00287	CcSEcCtD
Phenylephrine—Paraesthesia—Captopril—systemic scleroderma	0.00182	0.00287	CcSEcCtD
Phenylephrine—Palpitations—Leflunomide—systemic scleroderma	0.0018	0.00285	CcSEcCtD
Phenylephrine—Dyspnoea—Captopril—systemic scleroderma	0.0018	0.00285	CcSEcCtD
Phenylephrine—Arrhythmia—Lisinopril—systemic scleroderma	0.0018	0.00285	CcSEcCtD
Phenylephrine—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.0018	0.00284	CcSEcCtD
Phenylephrine—Agitation—Mycophenolic acid—systemic scleroderma	0.00179	0.00283	CcSEcCtD
Phenylephrine—Pulmonary oedema—Methotrexate—systemic scleroderma	0.00177	0.0028	CcSEcCtD
Phenylephrine—Mental disorder—Lisinopril—systemic scleroderma	0.00177	0.00279	CcSEcCtD
Phenylephrine—Dizziness—Pentoxifylline—systemic scleroderma	0.00176	0.00279	CcSEcCtD
Phenylephrine—Hypertension—Leflunomide—systemic scleroderma	0.00176	0.00279	CcSEcCtD
Phenylephrine—Syncope—Mycophenolic acid—systemic scleroderma	0.00175	0.00276	CcSEcCtD
Phenylephrine—Chest pain—Leflunomide—systemic scleroderma	0.00174	0.00275	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00173	0.00273	CcSEcCtD
Phenylephrine—Tension—Lisinopril—systemic scleroderma	0.00172	0.00272	CcSEcCtD
Phenylephrine—Palpitations—Mycophenolic acid—systemic scleroderma	0.00172	0.00272	CcSEcCtD
Phenylephrine—Dysgeusia—Lisinopril—systemic scleroderma	0.00172	0.00272	CcSEcCtD
Phenylephrine—Skin disorder—Azathioprine—systemic scleroderma	0.00171	0.00271	CcSEcCtD
Phenylephrine—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00171	0.00271	CcSEcCtD
Phenylephrine—Nervousness—Lisinopril—systemic scleroderma	0.0017	0.00269	CcSEcCtD
Phenylephrine—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.0017	0.00269	CcSEcCtD
Phenylephrine—Vomiting—Pentoxifylline—systemic scleroderma	0.0017	0.00268	CcSEcCtD
Phenylephrine—Rash—Pentoxifylline—systemic scleroderma	0.00168	0.00266	CcSEcCtD
Phenylephrine—Hypertension—Mycophenolic acid—systemic scleroderma	0.00168	0.00266	CcSEcCtD
Phenylephrine—Dermatitis—Pentoxifylline—systemic scleroderma	0.00168	0.00266	CcSEcCtD
Phenylephrine—Headache—Pentoxifylline—systemic scleroderma	0.00167	0.00264	CcSEcCtD
Phenylephrine—Chest pain—Mycophenolic acid—systemic scleroderma	0.00166	0.00262	CcSEcCtD
Phenylephrine—Vision blurred—Lisinopril—systemic scleroderma	0.00165	0.00261	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00165	0.0026	CcSEcCtD
Phenylephrine—Tremor—Lisinopril—systemic scleroderma	0.00164	0.0026	CcSEcCtD
Phenylephrine—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.00164	0.00259	CcSEcCtD
Phenylephrine—Nervous system disorder—Leflunomide—systemic scleroderma	0.00163	0.00258	CcSEcCtD
Phenylephrine—Pruritus—Mometasone—systemic scleroderma	0.00163	0.00257	CcSEcCtD
Phenylephrine—Tachycardia—Leflunomide—systemic scleroderma	0.00163	0.00257	CcSEcCtD
Phenylephrine—Skin disorder—Leflunomide—systemic scleroderma	0.00162	0.00256	CcSEcCtD
Phenylephrine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00161	0.00255	CcSEcCtD
Phenylephrine—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.0016	0.00253	CcSEcCtD
Phenylephrine—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00159	0.00252	CcSEcCtD
Phenylephrine—Nausea—Pentoxifylline—systemic scleroderma	0.00158	0.0025	CcSEcCtD
Phenylephrine—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00158	0.00249	CcSEcCtD
Phenylephrine—Syncope—Lisinopril—systemic scleroderma	0.00157	0.00249	CcSEcCtD
Phenylephrine—Shock—Mycophenolic acid—systemic scleroderma	0.00156	0.00247	CcSEcCtD
Phenylephrine—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00156	0.00246	CcSEcCtD
Phenylephrine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00155	0.00245	CcSEcCtD
Phenylephrine—Palpitations—Lisinopril—systemic scleroderma	0.00155	0.00245	CcSEcCtD
Phenylephrine—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00155	0.00245	CcSEcCtD
Phenylephrine—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00154	0.00244	CcSEcCtD
Phenylephrine—Loss of consciousness—Lisinopril—systemic scleroderma	0.00154	0.00244	CcSEcCtD
Phenylephrine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00154	0.00243	CcSEcCtD
Phenylephrine—Visual disturbance—Methotrexate—systemic scleroderma	0.00153	0.00241	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00152	0.00241	CcSEcCtD
Phenylephrine—Tension—Mycophenolate mofetil—systemic scleroderma	0.00151	0.00238	CcSEcCtD
Phenylephrine—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00151	0.00238	CcSEcCtD
Phenylephrine—Paraesthesia—Leflunomide—systemic scleroderma	0.0015	0.00236	CcSEcCtD
Phenylephrine—Chest pain—Lisinopril—systemic scleroderma	0.00149	0.00236	CcSEcCtD
Phenylephrine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00149	0.00236	CcSEcCtD
Phenylephrine—Dyspnoea—Leflunomide—systemic scleroderma	0.00149	0.00235	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00148	0.00234	CcSEcCtD
Phenylephrine—Vomiting—Mometasone—systemic scleroderma	0.00146	0.00231	CcSEcCtD
Phenylephrine—Sweating increased—Prednisone—systemic scleroderma	0.00146	0.0023	CcSEcCtD
Phenylephrine—Rash—Mometasone—systemic scleroderma	0.00145	0.00229	CcSEcCtD
Phenylephrine—Dermatitis—Mometasone—systemic scleroderma	0.00145	0.00229	CcSEcCtD
Phenylephrine—Headache—Mometasone—systemic scleroderma	0.00144	0.00228	CcSEcCtD
Phenylephrine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00144	0.00228	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00144	0.00227	CcSEcCtD
Phenylephrine—Pruritus—Captopril—systemic scleroderma	0.00143	0.00226	CcSEcCtD
Phenylephrine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00143	0.00226	CcSEcCtD
Phenylephrine—Pain—Leflunomide—systemic scleroderma	0.00143	0.00225	CcSEcCtD
Phenylephrine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00142	0.00224	CcSEcCtD
Phenylephrine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00141	0.00223	CcSEcCtD
Phenylephrine—Shock—Lisinopril—systemic scleroderma	0.00141	0.00223	CcSEcCtD
Phenylephrine—Tachycardia—Lisinopril—systemic scleroderma	0.0014	0.00221	CcSEcCtD
Phenylephrine—Skin disorder—Lisinopril—systemic scleroderma	0.00139	0.0022	CcSEcCtD
Phenylephrine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00138	0.00219	CcSEcCtD
Phenylephrine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00138	0.00218	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00137	0.00217	CcSEcCtD
Phenylephrine—Nausea—Mometasone—systemic scleroderma	0.00137	0.00216	CcSEcCtD
Phenylephrine—Pain—Mycophenolic acid—systemic scleroderma	0.00136	0.00215	CcSEcCtD
Phenylephrine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00136	0.00215	CcSEcCtD
Phenylephrine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00135	0.00214	CcSEcCtD
Phenylephrine—Dizziness—Captopril—systemic scleroderma	0.00134	0.00211	CcSEcCtD
Phenylephrine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00133	0.0021	CcSEcCtD
Phenylephrine—Urticaria—Leflunomide—systemic scleroderma	0.00132	0.00209	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.00131	0.00208	CcSEcCtD
Phenylephrine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00131	0.00207	CcSEcCtD
Phenylephrine—Myocardial infarction—Prednisone—systemic scleroderma	0.00131	0.00207	CcSEcCtD
Phenylephrine—Hypersensitivity—Azathioprine—systemic scleroderma	0.0013	0.00205	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.0013	0.00205	CcSEcCtD
Phenylephrine—Paraesthesia—Lisinopril—systemic scleroderma	0.00129	0.00203	CcSEcCtD
Phenylephrine—Vomiting—Captopril—systemic scleroderma	0.00129	0.00203	CcSEcCtD
Phenylephrine—Dyspnoea—Lisinopril—systemic scleroderma	0.00128	0.00202	CcSEcCtD
Phenylephrine—Rash—Captopril—systemic scleroderma	0.00127	0.00201	CcSEcCtD
Phenylephrine—Dermatitis—Captopril—systemic scleroderma	0.00127	0.00201	CcSEcCtD
Phenylephrine—Headache—Captopril—systemic scleroderma	0.00127	0.002	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00124	0.00195	CcSEcCtD
Phenylephrine—Shock—Mycophenolate mofetil—systemic scleroderma	0.00123	0.00195	CcSEcCtD
Phenylephrine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00123	0.00194	CcSEcCtD
Phenylephrine—Hypersensitivity—Leflunomide—systemic scleroderma	0.00123	0.00194	CcSEcCtD
Phenylephrine—Pain—Lisinopril—systemic scleroderma	0.00122	0.00194	CcSEcCtD
Phenylephrine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00122	0.00194	CcSEcCtD
Phenylephrine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00122	0.00193	CcSEcCtD
Phenylephrine—Bradycardia—Prednisone—systemic scleroderma	0.00122	0.00193	CcSEcCtD
Phenylephrine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00121	0.00192	CcSEcCtD
Phenylephrine—Nausea—Captopril—systemic scleroderma	0.0012	0.0019	CcSEcCtD
Phenylephrine—Pruritus—Leflunomide—systemic scleroderma	0.00118	0.00186	CcSEcCtD
Phenylephrine—Dizziness—Azathioprine—systemic scleroderma	0.00117	0.00184	CcSEcCtD
Phenylephrine—Urticaria—Lisinopril—systemic scleroderma	0.00114	0.0018	CcSEcCtD
Phenylephrine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00113	0.00178	CcSEcCtD
Phenylephrine—Pruritus—Mycophenolic acid—systemic scleroderma	0.00112	0.00178	CcSEcCtD
Phenylephrine—Vomiting—Azathioprine—systemic scleroderma	0.00112	0.00177	CcSEcCtD
Phenylephrine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00177	CcSEcCtD
Phenylephrine—Rash—Azathioprine—systemic scleroderma	0.00111	0.00176	CcSEcCtD
Phenylephrine—Dermatitis—Azathioprine—systemic scleroderma	0.00111	0.00176	CcSEcCtD
Phenylephrine—Headache—Azathioprine—systemic scleroderma	0.00111	0.00175	CcSEcCtD
Phenylephrine—Dizziness—Leflunomide—systemic scleroderma	0.0011	0.00174	CcSEcCtD
Phenylephrine—Angiopathy—Prednisone—systemic scleroderma	0.00109	0.00172	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00171	CcSEcCtD
Phenylephrine—Immune system disorder—Prednisone—systemic scleroderma	0.00108	0.00171	CcSEcCtD
Phenylephrine—Pain—Mycophenolate mofetil—systemic scleroderma	0.00107	0.0017	CcSEcCtD
Phenylephrine—Arrhythmia—Prednisone—systemic scleroderma	0.00107	0.00169	CcSEcCtD
Phenylephrine—Vomiting—Leflunomide—systemic scleroderma	0.00106	0.00167	CcSEcCtD
Phenylephrine—Hypersensitivity—Lisinopril—systemic scleroderma	0.00105	0.00167	CcSEcCtD
Phenylephrine—Dizziness—Mycophenolic acid—systemic scleroderma	0.00105	0.00166	CcSEcCtD
Phenylephrine—Rash—Leflunomide—systemic scleroderma	0.00105	0.00166	CcSEcCtD
Phenylephrine—Dermatitis—Leflunomide—systemic scleroderma	0.00105	0.00166	CcSEcCtD
Phenylephrine—Mental disorder—Prednisone—systemic scleroderma	0.00105	0.00166	CcSEcCtD
Phenylephrine—Nausea—Azathioprine—systemic scleroderma	0.00105	0.00166	CcSEcCtD
Phenylephrine—Headache—Leflunomide—systemic scleroderma	0.00104	0.00165	CcSEcCtD
Phenylephrine—Pruritus—Lisinopril—systemic scleroderma	0.00101	0.0016	CcSEcCtD
Phenylephrine—Vomiting—Mycophenolic acid—systemic scleroderma	0.00101	0.0016	CcSEcCtD
Phenylephrine—Rash—Mycophenolic acid—systemic scleroderma	0.001	0.00158	CcSEcCtD
Phenylephrine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.001	0.00158	CcSEcCtD
Phenylephrine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000997	0.00158	CcSEcCtD
Phenylephrine—Headache—Mycophenolic acid—systemic scleroderma	0.000996	0.00157	CcSEcCtD
Phenylephrine—Nausea—Leflunomide—systemic scleroderma	0.00099	0.00156	CcSEcCtD
Phenylephrine—Vision blurred—Prednisone—systemic scleroderma	0.000982	0.00155	CcSEcCtD
Phenylephrine—Visual impairment—Methotrexate—systemic scleroderma	0.000964	0.00152	CcSEcCtD
Phenylephrine—Agitation—Prednisone—systemic scleroderma	0.000958	0.00151	CcSEcCtD
Phenylephrine—Dizziness—Lisinopril—systemic scleroderma	0.000947	0.0015	CcSEcCtD
Phenylephrine—Nausea—Mycophenolic acid—systemic scleroderma	0.000944	0.00149	CcSEcCtD
Phenylephrine—Syncope—Prednisone—systemic scleroderma	0.000934	0.00148	CcSEcCtD
Phenylephrine—Cardiac disorder—Methotrexate—systemic scleroderma	0.000928	0.00147	CcSEcCtD
Phenylephrine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000924	0.00146	CcSEcCtD
Phenylephrine—Loss of consciousness—Prednisone—systemic scleroderma	0.000916	0.00145	CcSEcCtD
Phenylephrine—Vomiting—Lisinopril—systemic scleroderma	0.00091	0.00144	CcSEcCtD
Phenylephrine—Angiopathy—Methotrexate—systemic scleroderma	0.000908	0.00143	CcSEcCtD
Phenylephrine—Immune system disorder—Methotrexate—systemic scleroderma	0.000904	0.00143	CcSEcCtD
Phenylephrine—Rash—Lisinopril—systemic scleroderma	0.000903	0.00143	CcSEcCtD
Phenylephrine—Dermatitis—Lisinopril—systemic scleroderma	0.000902	0.00143	CcSEcCtD
Phenylephrine—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000902	0.00142	CcSEcCtD
Phenylephrine—Hypertension—Prednisone—systemic scleroderma	0.0009	0.00142	CcSEcCtD
Phenylephrine—Headache—Lisinopril—systemic scleroderma	0.000897	0.00142	CcSEcCtD
Phenylephrine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000888	0.0014	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000881	0.00139	CcSEcCtD
Phenylephrine—Mental disorder—Methotrexate—systemic scleroderma	0.000876	0.00139	CcSEcCtD
Phenylephrine—Dysgeusia—Methotrexate—systemic scleroderma	0.000853	0.00135	CcSEcCtD
Phenylephrine—Nausea—Lisinopril—systemic scleroderma	0.000851	0.00134	CcSEcCtD
Phenylephrine—Shock—Prednisone—systemic scleroderma	0.000837	0.00132	CcSEcCtD
Phenylephrine—Nervous system disorder—Prednisone—systemic scleroderma	0.000834	0.00132	CcSEcCtD
Phenylephrine—Tachycardia—Prednisone—systemic scleroderma	0.00083	0.00131	CcSEcCtD
Phenylephrine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00083	0.00131	CcSEcCtD
Phenylephrine—Skin disorder—Prednisone—systemic scleroderma	0.000826	0.00131	CcSEcCtD
Phenylephrine—Hyperhidrosis—Prednisone—systemic scleroderma	0.000822	0.0013	CcSEcCtD
Phenylephrine—Vision blurred—Methotrexate—systemic scleroderma	0.000821	0.0013	CcSEcCtD
Phenylephrine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000798	0.00126	CcSEcCtD
Phenylephrine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000791	0.00125	CcSEcCtD
Phenylephrine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00079	0.00125	CcSEcCtD
Phenylephrine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000786	0.00124	CcSEcCtD
Phenylephrine—Paraesthesia—Prednisone—systemic scleroderma	0.000764	0.00121	CcSEcCtD
Phenylephrine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000745	0.00118	CcSEcCtD
Phenylephrine—Chest pain—Methotrexate—systemic scleroderma	0.000741	0.00117	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000736	0.00116	CcSEcCtD
Phenylephrine—Nervous system disorder—Methotrexate—systemic scleroderma	0.000697	0.0011	CcSEcCtD
Phenylephrine—Skin disorder—Methotrexate—systemic scleroderma	0.00069	0.00109	CcSEcCtD
Phenylephrine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000687	0.00109	CcSEcCtD
Phenylephrine—Urticaria—Prednisone—systemic scleroderma	0.000676	0.00107	CcSEcCtD
Phenylephrine—Paraesthesia—Methotrexate—systemic scleroderma	0.000638	0.00101	CcSEcCtD
Phenylephrine—Dyspnoea—Methotrexate—systemic scleroderma	0.000634	0.001	CcSEcCtD
Phenylephrine—Hypersensitivity—Prednisone—systemic scleroderma	0.000627	0.00099	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000614	0.00097	CcSEcCtD
Phenylephrine—Pain—Methotrexate—systemic scleroderma	0.000608	0.000961	CcSEcCtD
Phenylephrine—Pruritus—Prednisone—systemic scleroderma	0.000602	0.000951	CcSEcCtD
Phenylephrine—Urticaria—Methotrexate—systemic scleroderma	0.000565	0.000892	CcSEcCtD
Phenylephrine—Dizziness—Prednisone—systemic scleroderma	0.000562	0.000889	CcSEcCtD
Phenylephrine—Vomiting—Prednisone—systemic scleroderma	0.000541	0.000855	CcSEcCtD
Phenylephrine—Rash—Prednisone—systemic scleroderma	0.000536	0.000847	CcSEcCtD
Phenylephrine—Dermatitis—Prednisone—systemic scleroderma	0.000536	0.000847	CcSEcCtD
Phenylephrine—Headache—Prednisone—systemic scleroderma	0.000533	0.000842	CcSEcCtD
Phenylephrine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000524	0.000828	CcSEcCtD
Phenylephrine—Nausea—Prednisone—systemic scleroderma	0.000505	0.000798	CcSEcCtD
Phenylephrine—Pruritus—Methotrexate—systemic scleroderma	0.000503	0.000795	CcSEcCtD
Phenylephrine—Dizziness—Methotrexate—systemic scleroderma	0.00047	0.000743	CcSEcCtD
Phenylephrine—Vomiting—Methotrexate—systemic scleroderma	0.000452	0.000714	CcSEcCtD
Phenylephrine—Rash—Methotrexate—systemic scleroderma	0.000448	0.000708	CcSEcCtD
Phenylephrine—Dermatitis—Methotrexate—systemic scleroderma	0.000448	0.000708	CcSEcCtD
Phenylephrine—Headache—Methotrexate—systemic scleroderma	0.000445	0.000704	CcSEcCtD
Phenylephrine—Nausea—Methotrexate—systemic scleroderma	0.000422	0.000667	CcSEcCtD
